The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

RICTOR  -  RPTOR independent companion of MTOR,...

Homo sapiens

Synonyms: AVO3, AVO3 homolog, KIAA1999, MGC39830, PIA, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of RICTOR

  • Signaling mediated by the mammalian target of rapamycin kinase (mTOR) is activated during human cytomegalovirus (HCMV) infection. mTOR is found in two complexes differing by the binding partner, rictor or raptor [1].
 

High impact information on RICTOR

  • Disruption of the Rictor gene in mice results in embryonic lethality and ablates Akt phosphorylation [2].
  • The distinct complex of mTOR, mLST8, and rictor (mTORC2) does not interact with FKBP12-rapamycin and is not thought to be rapamycin sensitive. mTORC2 phosphorylates and activates Akt/PKB, a key regulator of cell survival [3].
  • Surprisingly, the inhibitory effects of rapamycin on viral growth are primarily due to the presence of rictor, not raptor [1].
  • Human cytomegalovirus infection alters the substrate specificities and rapamycin sensitivities of raptor- and rictor-containing complexes [1].
 

Biological context of RICTOR

References

  1. Human cytomegalovirus infection alters the substrate specificities and rapamycin sensitivities of raptor- and rictor-containing complexes. Kudchodkar, S.B., Yu, Y., Maguire, T.G., Alwine, J.C. Proc. Natl. Acad. Sci. U.S.A. (2006) [Pubmed]
  2. Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity. Yang, Q., Inoki, K., Ikenoue, T., Guan, K.L. Genes Dev. (2006) [Pubmed]
  3. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Sarbassov, d.o.s. .D., Ali, S.M., Sengupta, S., Sheen, J.H., Hsu, P.P., Bagley, A.F., Markhard, A.L., Sabatini, D.M. Mol. Cell (2006) [Pubmed]
  4. Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways. Liu, L., Li, F., Cardelli, J.A., Martin, K.A., Blenis, J., Huang, S. Oncogene (2006) [Pubmed]
 
WikiGenes - Universities